| ²é¿´: 585 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
wyying¶Ò»»¹ó±ö
|
[ÇóÖú]
Ó¢·ÖÐÈóÉ«2
|
||
|
Impact of oxidative stress during pregnancy on fetal epigenetic patterns and early origin of vascular diseases Epidemiological studies have led scientists to postulate the developmental origins of health and disease hypothesis for noncommunicable diseases such as diabetes, cardiovascular diseases, hypertension, and obesity. However, the cellular and molecular mechanisms involved in the development of these diseases are not well understood. In various animal models, it has been observed that oxidative stress during pregnancy is associated with the early development of endothelial dysfunction in offspring. This phenomenon suggests that endothelial dysfunction may initiate in the uterus and could lead to increased risk of cardiovascular disease later in life. Currently, it is known that many of the fetal adaptive responses to environmental factors are mediated by epigenetic changes in the genome, especially by the degree of methylation in cytosines in the promoter regions of genes. These findings suggest that the establishment of a particular epigenetic pattern in the genome may be generated by oxidative stress. KEYWORDS: oxidative stress; epigenetics; pregnancy; endothelial dysfunction; cardiovascular diseases; fetal programming. ÔÐÆÚÑõ»¯Ó¦¼¤¶ÔÌ¥¶ù±í¹ÛÒÅ´«Ä£Ê½ºÍѪ¹Ü¼²²¡ÔçÆÚÆðÔ´µÄÓ°Ïì ÕªÒª ͨ¹ýÁ÷Ðв¡Ñ§Ñо¿£¬¿ÆÑ§¼ÒÃÇÌá³öÁË·Ç´«È¾ÐÔ¼²²¡µÄ½¡¿µºÍ¼²²¡µÄ·¢ÓýÆðÔ´¼ÙÉ裬ÈçÌÇÄò²¡¡¢ÐÄѪ¹Ü¼²²¡¡¢¸ßѪѹºÍ·ÊÅÖ¡£È»¶ø£¬¶Ô·¢ÉúÕâЩ¼²²¡µÄϸ°û·Ö×Ó×÷ÓûúÖÆ»¹Î´³ä·ÖÁ˽⡣¶àÖÖ¶¯ÎïÄ£ÐÍÒѾ¹Û²ìµ½ÔÐÆÚÑõ»¯Ó¦¼¤Óë×Ó´úÄÚÆ¤¹¦ÄÜÕϰµÄÔçÆÚ·¢Õ¹´æÔÚÏà¹Ø¡£Õâ±íÃ÷ÄÚÆ¤¹¦ÄÜÕϰ¿ÉÄÜÔÚ×Ó¹¬ÄÚÐγɣ¬²¢Ôö¼ÓÉúÃüºóÆÚ»¼ÐÄѪ¹Ü¼²²¡µÄ·çÏÕ¡£Ä¿Ç°¹ã·ºÈϿɵÄÊÇÌ¥¶ù¶Ô»·¾³ÒòËØµÄÊÊÓ¦ÐÔ·´Ó¦Óɱí¹ÛÒÅ´«»ùÒò×éµÄ±ä»¯ÒýÆðµÄ£¬ÌرðÊÇ»ùÒòÆô¶¯ÇøµÄ°ûºËà×़׻ù»¯³Ì¶È¡£ÕâЩÑо¿±íÃ÷»ùÒò×éÖÐÌØ¶¨µÄ±í¹ÛÒÅ´«Ä£Ê½¿ÉÄÜÓÉÑõ»¯Ó¦¼¤µ¼Ö¡£ ¹Ø¼ü´Ê£ºÑõ»¯Ó¦¼¤; ±í¹ÛÒÅ´«Ñ§; »³ÔÐ; ÄÚÆ¤¹¦ÄÜÕϰ; ÐÄѪ¹Ü¼²²¡; Ì¥¶ù³ÌÐò»¯¡£ Protective role of dairy and its constituents on vascular function independent of blood pressure¨Clowering activities Abstract Greater intakes of dairy are frequently associated with reduced risk of cardiovascular disease. These observational studies have served as the basis for controlled interventions aimed at defining the cardioprotective mechanisms of dairy. Understanding these relationships is of public health importance because most of the US population fails to meet dietary recommendations for dairy, suggesting that many individuals could lower their cardiovascular disease risk by relatively simple dietary modification. Clinical studies investigating the acute ingestion of dairy or its constituents, including short-term (¡Ü2 week) supplementation studies or those assessing postprandial responses, have largely shown benefits on vascular function without concomitant improvements in blood pressure. Chronic interventions have been less conclusive, with some showing benefits and others indicating a lack of improvement in vascular function regardless of blood pressure changes. Vasoprotective activities of dairy are likely mediated through improvements in nitric oxide bioavailability, oxidative stress, inflammation, and insulin resistance. Future controlled studies are needed to determine if these health benefits are mediated directly by dairy or indirectly by displacing other dietary components that otherwise impair vascular health. KEYWORDS: cardiovascular disease; dairy; low-fat dairy; nitric oxide; vascular function; whey protein. ÈéÖÆÆ·¼°Æä³É·Ö¶ÔѪ¹Ü¹¦Äܵı£»¤×÷ÓöÀÁ¢ÓÚ½µÑªÑ¹ ÕªÒª ÉãÈë½Ï¶àµÄÈéÖÆÆ·Í¨³£¿ÉÒÔ½µµÍ»¼ÐÄѪ¹Ü¼²²¡µÄ·çÏÕ¡£ÕâЩ¹Û²ìÐÔÑо¿ÒѳÉΪȷ¶¨ÈéÖÆÆ·±£»¤ÐÄѪ¹Ü»úÖÆµÄ¶ÔÕÕ¸ÉÔ¤µÄÒÀ¾Ý¡£ÒòΪ¾ø´ó¶àÊýÃÀ¹úÈËδÄÜ´ïµ½ÈéÖÆÆ·µÄÿÈÕÍÆ¼öÁ¿£¬Á˽âÕâЩ¹ØÁª¶Ô¹«¹²ÎÀ½¡¿µ·Ç³£ÖØÒª£¬ºÜ¶à¸öÌå¿ÉÒÔͨ¹ý¼òµ¥µÄÉÅʳ½á¹¹¸Ä±äÀ´½µµÍÐÄѪ¹Ü¼²²¡µÄ·çÏÕ¡£Ì½ÌÖ¿ìËÙÉãÈëÈéÖÆÆ·»òÆä³É·ÖµÄÁÙ´²Ñо¿£¬°üÀ¨¶ÌÆÚ£¨¡Ü2ÖÜÄÚ£©²¹³äÑо¿»òÆÀ¼Û²Íºó·´Ó¦µÄÑо¿£¬Ö÷Òª±íÏÖΪѪ¹Ü¹¦ÄܵÄÒæ´¦²¢²»°éÓÐѪѹµÄ¸ÄÉÆ¡£ÂýÐÔ¸ÉԤĿǰ»¹È±·¦Ö¤¾Ý£¬²¿·ÖÈ·¶¨ÓÐÒæ£¬µ«ÆäËûÑо¿±íÃ÷¾¡¹ÜÓÐѪѹ¸Ä±äµ«Ã»ÓиÄÉÆÑª¹Ü¹¦ÄÜ¡£ÈéÖÆÆ·µÄѪ¹Ü±£»¤¹¦ÄÜ¿ÉÄÜÊÇͨ¹ý¸ÄÉÆÒ»Ñõ»¯µªµÄÉúÎïÀûÓöȡ¢Ñõ»¯Ó¦¼¤¡¢Ñ×Ö¢·´Ó¦ºÍÒȵºËصֿ¹À´µ÷½ÚµÄ¡£Î´À´Ø½ÐèÑо¿½¡¿µÒæ´¦ÊÇÈéÖÆÆ·Ö±½Óµ÷½Ú»¹ÊǼä½ÓÌæ´úÆäËû¿ÉÄÜ»áËðº¦Ñª¹Ü½¡¿µµÄÉÅʳ³É·ÖÀ´ÊµÏÖ¡£ ¹Ø¼ü´Ê£ºÐÄѪ¹Ü¼²²¡; ÈéÖÆÆ·; µÍÖ¬ÈéÖÆÆ·; Ò»Ñõ»¯µª; Ѫ¹Ü¹¦ÄÜ; ÈéÇåµ°°×¡£ |
» ²ÂÄãϲ»¶
0856£¬269·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸ÉϺ£º£Ñó´óѧ083200ʳƷѧ˶£¬Çóµ÷¼Á£¬½ÓÊÜÆäËûרҵ
ÒѾÓÐ4È˻ظ´
070300»¯Ñ§279Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
295²ÄÁϹ¤³Ìר˶Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
805600ר˶²ÄÁÏÓ뻯¹¤348·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
Çóµ÷¼ÁÍÆ¼ö ²ÄÁÏ 304
ÒѾÓÐ21È˻ظ´
288Çóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó ²ÄÁÏÓ뻯¹¤
ÒѾÓÐ27È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ14È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ9È˻ظ´
iamliyang91
Ö÷¹ÜÇø³¤
![]()
![]()
![]()
![]()
- ·ÒëEPI: 3
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2487.1
- É¢½ð: 5
- Ìû×Ó: 285
- ÔÚÏß: 88.5Сʱ
- ³æºÅ: 3765998
- ×¢²á: 2015-03-26
- ÐÔ±ð: GG
- רҵ: ð¤Ä¤ÃâÒßѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
wyying: ½ð±Ò+3, ·ÒëEPI+1, ¡ï¡ï¡ïºÜÓаïÖú 2015-05-26 00:48:08
wyying(RXMCDM´ú·¢): ½ð±Ò+3 2015-06-08 08:45:24
wyying: ½ð±Ò+3, ·ÒëEPI+1, ¡ï¡ï¡ïºÜÓаïÖú 2015-05-26 00:48:08
wyying(RXMCDM´ú·¢): ½ð±Ò+3 2015-06-08 08:45:24
|
1.È»¶ø£¬¶Ô·¢ÉúÕâЩ¼²²¡µÄϸ°û·Ö×Ó×÷ÓûúÖÆ»¹Î´³ä·ÖÁ˽⡣ ¸ÄΪ£º¶ÔÕâЩ¼²²¡µÄϸ°û·Ö×ÓˮƽµÄ»úÖÆ»¹²»Çå³þ¡£ 2.¶àÖÖ¶¯ÎïÄ£ÐÍÒѾ¹Û²ìµ½ÔÐÆÚÑõ»¯Ó¦¼¤Óë×Ó´úÄÚÆ¤¹¦ÄÜÕϰµÄÔçÆÚ·¢Õ¹´æÔÚÏà¹Ø¡£ ¸ÄΪ£ºÒÑÔÚ¸÷ÖÖ¶¯ÎïÄ£ÐÍÖй۲쵽£¬ÔÐÆÚÑõ»¯Ó¦¼¤Óë×Ó´úÄÚÆ¤¹¦ÄÜÕϰµÄÔçÆÚ·¢Õ¹Óйء£ 3.Õâ±íÃ÷ÄÚÆ¤¹¦ÄÜÕϰ¿ÉÄÜÔÚ×Ó¹¬ÄÚÐγɣ¬²¢Ôö¼ÓÉúÃüºóÆÚ»¼ÐÄѪ¹Ü¼²²¡µÄ·çÏÕ¡£ ¸ÄΪ£ºÕâ±íÃ÷ÄÚÆ¤¹¦ÄÜÕϰ¿ÉÄÜÔÚ×Ó¹¬ÄÚÐγɣ¬²¢ÇÒµ¼ÖÂÒÔºó»¼ÐÄѪ¹Ü¼²²¡µÄ·çÏÕÔö¼Ó¡£ 4.δÀ´Ø½ÐèÑо¿½¡¿µÒæ´¦ÊÇÈéÖÆÆ·Ö±½Óµ÷½Ú»¹ÊǼä½ÓÌæ´úÆäËû¿ÉÄÜ»áËðº¦Ñª¹Ü½¡¿µµÄÉÅʳ³É·ÖÀ´ÊµÏÖ¡£ ¸ÄΪ£ºÎ´À´Ø½ÐèÑо¿ÕâЩ¸ÄÉÆ½¡¿µµÄЧ¹ûÊÇÓÉÈéÖÆÆ·Ö±½Ó½éµ¼»¹ÊǼä½ÓÌæ´úÆäËû¿ÉÄÜ»áËðº¦Ñª¹Ü½¡¿µµÄÉÅʳ³É·ÖÀ´ÊµÏÖ¡£ |
2Â¥2015-05-10 20:49:29














»Ø¸´´ËÂ¥